Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Korean Journal of Medicine ; : 496-501, 2011.
Article in Korean | WPRIM | ID: wpr-164065

ABSTRACT

A 65-year-old woman was referred for management of chest pain and ST segment elevation on electrocardiography. Emergency coronary angiography revealed a well demarcated thrombus that near totally occluded the mid portion of the left anterior descending artery, with a Thrombolysis In Myocardial Infarction (TIMI) flow grade 1, and a fusiform aneurysm on the left main coronary artery. No significant stenosis was observed after aspiration of the thrombus; however, complete coronary reperfusion by urgent aspiration did not improve her dyspnea and tachypnea. Echocardiography revealed a D-shaped left ventricle; thus, we performed a chest computed tomography scan and diagnosed a pulmonary embolism. The patient's coagulation studies were normal. She was prescribed chronic anticoagulation, and we carried out transthoracic echocardiography using second harmonic imaging with agitated saline. Second harmonic imaging with the Valsalva maneuver revealed no right-to-left shunt. We report here a case of concurrent coronary embolism and pulmonary embolism without right-to-left shunt.


Subject(s)
Aged , Female , Humans , Aneurysm , Arteries , Chest Pain , Constriction, Pathologic , Coronary Aneurysm , Coronary Angiography , Coronary Vessels , Dihydroergotamine , Dyspnea , Echocardiography , Electrocardiography , Embolism , Emergencies , Myocardial Infarction , Myocardial Reperfusion , Pulmonary Embolism , Tachypnea , Thorax , Thromboembolism , Thrombosis , Valsalva Maneuver
2.
Korean Circulation Journal ; : 334-337, 2011.
Article in English | WPRIM | ID: wpr-148010

ABSTRACT

Myocardial involvement with clinical symptoms is a rare manifestation of systemic lupus erythematosus (SLE), despite the relatively high prevalence of myocarditis at autopsies of SLE patients. In this review, we report the case of a 19-year-old male SLE patient who initially presented with myopericarditis and was successfully treated with high dose of glucocorticoids.


Subject(s)
Humans , Male , Young Adult , Autopsy , Glucocorticoids , Lupus Erythematosus, Systemic , Myocarditis , Pericarditis , Prevalence
3.
Korean Journal of Medicine ; : 181-186, 2010.
Article in Korean | WPRIM | ID: wpr-102111

ABSTRACT

It is essential during extracorporeal membrane oxygenation (ECMO) to extend the activated clotting time (ACT) using anticoagulants to prevent blood clot formation. Traditionally, heparin has been used as an anticoagulant during ECMO. Hemorrhaging due to systemic heparinization is considered a major complication of ECMO. A 48-year-old man was admitted due to cardiogenic shock with acute myocardial infarction. ECMO was instituted because of recurrent ventricular tachycardia and refractory shock. We used nafamostat mesilate (Futhan) as an anticoagulant to reduce hemorrhagic complications. The total bypass time was 153 h. The average dose of nafamostat mesilate was 2.64+/-1.11 mg/kg/h; the average ACT was 128.68+/-21.24 seconds. Only a few units were transfused, and there was no oxygenator failure or hemorrhagic complications. Thus, nafamostat mesilate may reduce the need for transfusions and hemorrhagic complications during ECMO.


Subject(s)
Humans , Middle Aged , Anticoagulants , Extracorporeal Membrane Oxygenation , Guanidines , Hemorrhage , Heparin , Mesylates , Myocardial Infarction , Oxygen , Oxygenators , Shock , Shock, Cardiogenic , Tachycardia, Ventricular
4.
Tuberculosis and Respiratory Diseases ; : 62-66, 2010.
Article in Korean | WPRIM | ID: wpr-166252

ABSTRACT

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) during severe acute respiratory failure helps to recover the pulmonary function. This study evaluated our experience with veno-venous ECMO in adult patients with acute respiratory failure. METHODS: From January 2007 to July 2009, ECMO was used on 54 patients. Of these 54 patients, 7 were placed on veno-venous ECMO for acute respiratory failure. The indications of ECMO were based on the lung dysfunction measured as a PaO2/FiO2 ratio <100 mm Hg on FiO2 of 1.0, or an arterial blood gas pH <7.25 due to hypercapnia despite the optimal treatment. EBS(R), Bio-pump(R), and Centrifugal Rotaflow pump(R) were used and all cannulations were performed percutaneously via both femoral veins. When the lung function was improved, an attempt was made to wean on ECMO at moderate ventilator settings followed by decannulation. RESULTS: Five of the 7 patients were male and the mean age was 46.3+/-18.3. The causes of acute respiratory failure were 3 cases of pneumonia, 2 near-drownings, 1 pulmonary hemorrhage due to acute hepatic failure and 1 mercury vapor poisoning. The mean support time of ECMO was 17.3+/-13.7 days. Of the 7 patients implanted with ECMO, 5 patients (71%) were weaned off ECMO and 3 patients (43%) survived to hospital discharge after a mean 89.6 hospital days. CONCLUSION: The early use of ECMO for acute respiratory failure in adults due to any cause is a good therapeutic option for those unresponsive to the optimal conventional treatments.


Subject(s)
Adult , Humans , Male , Catheterization , Extracorporeal Membrane Oxygenation , Femoral Vein , Hemorrhage , Hydrogen-Ion Concentration , Hypercapnia , Liver Failure, Acute , Lung , Near Drowning , Pneumonia , Respiratory Distress Syndrome , Respiratory Insufficiency , Ventilators, Mechanical
5.
Korean Circulation Journal ; : 37-41, 2009.
Article in English | WPRIM | ID: wpr-95334

ABSTRACT

A 48-year-old woman visited the emergency department with shock due to a urinary tract infection. The patient, who had a history of hypertension and diabetes mellitus, presented with precordial ST-segment elevation and Q waves, along with an increase of cardiac enzymes. An echocardiography showed moderately reduced systolic function, severe apical left ventricular ballooning, and a dynamic left ventricular outflow tract obstruction with a pressure gradient of 109 mmHg. Coronary angiography demonstrated normal coronary arteries. At the 1-month echocardiographic follow-up, the apical ballooning and left ventricular systolic function had recovered completely. There was no residual left ventricular intra-cavity gradient at rest, but it was induced in low-dose dobutamine stress-echocardiography. We demonstrated that dynamic left midventricular obstruction in the setting of either increased catecholamine stress or hypovolemia could develop Tako-tsubo cardiomyopathy.


Subject(s)
Female , Humans , Middle Aged , Coronary Angiography , Coronary Vessels , Diabetes Mellitus , Dobutamine , Echocardiography , Echocardiography, Stress , Emergencies , Follow-Up Studies , Hypertension , Hypovolemia , Shock , Takotsubo Cardiomyopathy , Urinary Tract Infections , Ventricular Outflow Obstruction
6.
Journal of Cardiovascular Ultrasound ; : 28-30, 2009.
Article in English | WPRIM | ID: wpr-18352

ABSTRACT

Danon disease is characterized clinically by the triad of cardiomyopathy, myopathy and mental retardation. It was originally reported as a lysosomal glycogen storage disease with normal acid maltase by Danon. Danon disease results from mutations in lysosome associated membrane protein-2 (LAMP-2) gene. The LAMP-2 gene is located on Xq24-25. We report a case of suspected Danon disease in patient who had hypertrophic cardiomyopathy and mental retardation along with abnormal findings in electromyography.


Subject(s)
Humans , alpha-Glucosidases , Cardiomyopathies , Cardiomyopathy, Hypertrophic , Glycogen Storage Disease , Glycogen Storage Disease Type IIb , Intellectual Disability , Lysosomes , Membranes , Muscular Diseases
7.
Korean Circulation Journal ; : 378-381, 2009.
Article in English | WPRIM | ID: wpr-151433

ABSTRACT

BACKGROUND AND OBJECTIVES: Right ventricular (RV) dysfunction is associated with a poor prognosis in patients with an acute pulmonary embolism (APE). We studied the role of electrocardiography and biomarkers for early detection and recovery of right ventricular dysfunction (RVD) in APE. SUBJECTS AND METHODS: The medical records of 48 consecutive patients diagnosed with APE using CT-angiography, at the Kangdong Sacred Heart Hospital, between January 2004 and February 2008 were reviewed retrospectively. RVD was assessed by serial echocardiography (ECG). Patients with one of the following were considered to have RVD: 1) RV dilatation (enddiastolic diameter >30 mm in the parasternal long axis view), 2) RV free wall hypokinesia, and 3) paradoxical septal systolic motion. We compared the electrocardiographic findings and the biomarkers for the early detection of RVD. RESULTS: The electrocardiographic findings showed T-wave inversion (TWI) in leads V1 to V3 with a sensitivity of 75% and a specificity of 95%, and a diagnostic accuracy of 80% for the detection of RVD, with positive and negative predictive values of 95.5% and 73.1%, respectively; these results were better than the biomarkers such as cardiac enzymes or B-type natriuretic peptide (BNP) for the early detection of RVD. TWIs persisted throughout the period of RVD, in contrast to a transient S1Q3T3 pattern detected during the acute phase only. CONCLUSION: TWIs in leads V1 to V3 had the greatest sensitivity and diagnostic accuracy for early detection of RVD, and normalization of the TWIs was associated with recovery of RVD in APE.


Subject(s)
Humans , Axis, Cervical Vertebra , Biomarkers , Dilatation , Echocardiography , Electrocardiography , Heart , Hominidae , Hypokinesia , Medical Records , Natriuretic Peptide, Brain , Prognosis , Pulmonary Embolism , Retrospective Studies , Sensitivity and Specificity , Ventricular Dysfunction, Right
8.
Journal of Cardiovascular Ultrasound ; : 120-123, 2006.
Article in Korean | WPRIM | ID: wpr-118418

ABSTRACT

Persistent tricuspid regurgitation (TR) caused by infarction or ischemia of right ventricle (RV) is rare and has not been reported by coronary vasospasm previously. We reported the two cases of patients with persistent right heart failure (HF) and severe TR by coronary vasospasm. After RV infarction or ischemia, two-dimensional (2D) echocardiographic examination revealed normal left ventricular function, but RV hypokinesia, RV and tricuspid annular dilation, and severe TR with normal appearance of tricuspid valve itself. Subsequent coronary angiography and cardiac catheterization revealed coronary vasospasm without significant coronary artery stenosis and pulmonary hypertension. Repeated echocardiography showed persistent right HF and severe TR at 5 years and 4 months later in respective cases. In conclusion, we suggest that RV infarction or ischemia with coronary vasospasm can be one of the causes for isolated TR and tricuspid annular dilation.


Subject(s)
Humans , Cardiac Catheterization , Cardiac Catheters , Coronary Angiography , Coronary Stenosis , Coronary Vasospasm , Echocardiography , Heart Failure , Heart Ventricles , Heart , Hypertension, Pulmonary , Hypokinesia , Infarction , Ischemia , Tricuspid Valve , Tricuspid Valve Insufficiency , Ventricular Function, Left
9.
Korean Journal of Nephrology ; : 1032-1036, 2002.
Article in Korean | WPRIM | ID: wpr-64311

ABSTRACT

Immunosuppressive medications after renal allograft transplantation have impacted the course of acute and chronic rejection: however, they have no defined effects on the prevention of recurrent and Glomerulonephritis (GN) in an allograft kidney. Authors experienced a case of rapidly progressive glomerulonephritis (RPGN). The 35-year-old female patient developed a rapid deterioration of renal function 4 years after renal transplantation. The allograft biopsy showed crescentic glomerulonephritis evolving from membranoproliferative glomerulonephritis (MPGN) type I. She was given pulse steroid and oral cyclophosphamide therapy immediately after the renal biopsy. Graft function stabilized and proteinuria decreased even though graft function did not recover to pre-treatment level and low grade proteinuria persisted.


Subject(s)
Adult , Female , Humans , Allografts , Biopsy , Cyclophosphamide , Glomerulonephritis , Glomerulonephritis, Membranoproliferative , Kidney Transplantation , Kidney , Proteinuria , Transplants
10.
Korean Circulation Journal ; : 507-511, 2001.
Article in Korean | WPRIM | ID: wpr-139319

ABSTRACT

Anthracyclines have been widely used in cancer therapy because of their efficacy in the treatment of various solid tumors and hem -atologic malignancy. Cumulative dose-related cardiotoxicity was a well-known toxicity of anthracyclines. Particularly, at total doses of more than 550 mg/m2, therapy with anthracyclines could produce irreversible cardiac injury. Anthracycline-induced cardiac toxicity was usually manifested by congestive heart failure or arrhythmia. In co- ntrast, acute myocardial infarction is a rare event of anthracycline-induced heart diseases. A 31-year-old man with non-Hodgkin lymphoma(NHL) and single cardiac risk factor, including smoking, was presented with chest pain after receiving 2nd CEOP-BLAM chemo-therapy. An electrocardiogram revealed ST segment elevation in inferior leads consistent with acute myocardial infarction. An echocardiogram revealed an ejection fraction of 60% and severe hypokinesia in inferior and anteroseptal wall. Three days later, coronary angiography revealed 50% of luminal stenosis of right coronary artery(RCA) and near total occlusion with large thrombi in m-RCA. After balloon angioplasty and stent insertion, the patient was transferred to coronary care unit and continuous intravenous heparin infusion was started. On the 10th days, the patient was discharged in good condition. Six months later, follow-up coronary angiography showed no significant lesion in right coronary artery. In a young man with NHL, we report an acute myocardial infarction after 2nd course of CEOP-BLAM chemotherapy with a review of relevant literatures.


Subject(s)
Adult , Humans , Angioplasty, Balloon , Anthracyclines , Arrhythmias, Cardiac , Chest Pain , Constriction, Pathologic , Coronary Angiography , Coronary Care Units , Coronary Vessels , Doxorubicin , Drug Therapy , Electrocardiography , Follow-Up Studies , Heart Diseases , Heart Failure , Heparin , Hypokinesia , Lymphoma, Non-Hodgkin , Myocardial Infarction , Phenobarbital , Risk Factors , Smoke , Smoking , Stents
11.
Korean Circulation Journal ; : 507-511, 2001.
Article in Korean | WPRIM | ID: wpr-139314

ABSTRACT

Anthracyclines have been widely used in cancer therapy because of their efficacy in the treatment of various solid tumors and hem -atologic malignancy. Cumulative dose-related cardiotoxicity was a well-known toxicity of anthracyclines. Particularly, at total doses of more than 550 mg/m2, therapy with anthracyclines could produce irreversible cardiac injury. Anthracycline-induced cardiac toxicity was usually manifested by congestive heart failure or arrhythmia. In co- ntrast, acute myocardial infarction is a rare event of anthracycline-induced heart diseases. A 31-year-old man with non-Hodgkin lymphoma(NHL) and single cardiac risk factor, including smoking, was presented with chest pain after receiving 2nd CEOP-BLAM chemo-therapy. An electrocardiogram revealed ST segment elevation in inferior leads consistent with acute myocardial infarction. An echocardiogram revealed an ejection fraction of 60% and severe hypokinesia in inferior and anteroseptal wall. Three days later, coronary angiography revealed 50% of luminal stenosis of right coronary artery(RCA) and near total occlusion with large thrombi in m-RCA. After balloon angioplasty and stent insertion, the patient was transferred to coronary care unit and continuous intravenous heparin infusion was started. On the 10th days, the patient was discharged in good condition. Six months later, follow-up coronary angiography showed no significant lesion in right coronary artery. In a young man with NHL, we report an acute myocardial infarction after 2nd course of CEOP-BLAM chemotherapy with a review of relevant literatures.


Subject(s)
Adult , Humans , Angioplasty, Balloon , Anthracyclines , Arrhythmias, Cardiac , Chest Pain , Constriction, Pathologic , Coronary Angiography , Coronary Care Units , Coronary Vessels , Doxorubicin , Drug Therapy , Electrocardiography , Follow-Up Studies , Heart Diseases , Heart Failure , Heparin , Hypokinesia , Lymphoma, Non-Hodgkin , Myocardial Infarction , Phenobarbital , Risk Factors , Smoke , Smoking , Stents
SELECTION OF CITATIONS
SEARCH DETAIL